Scopus Biopharma Inc (SCPS) Financials

$0.00

$-0.05 (-99.27%)

As on 07-Sep-2026 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	8.50	11.71	27.63	10.16	2.69	0.69
Operating Profit (EBIT)	-8.50	-11.71	-27.63	-10.16	-2.69	-0.69
Other Income	--	--	--	--	--	--
Profit before Tax	-8.50	-11.71	-26.95	-10.86	-2.69	-0.69
Provision for Tax	-0.11	-0.11	-1.46	0.71	0.00	--
Profit after Tax (Net Income)	-7.98	-11.61	-25.50	-11.57	-2.69	-0.69
Minority Interest	0.54	0.11	--	--	--	--
Consolidated Profit	-8.86	-11.61	-26.95	-10.86	-2.69	-0.69

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-9.45	-7.06	4.02	-1.83	-0.08	-0.01
Minority Interest	0.54	--	--	--	--	--
Non-Current Liabilities	--	--	--	2.28	--	--
Current Liabilities	11.00	7.45	4.17	3.81	0.85	0.14
Total Liabilities	11.00	0.39	8.19	1.97	0.77	0.13

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	0.00	0.00	0.00	0.00	0.00	--
Current Assets	0.50	0.39	8.18	1.97	0.77	0.13
Total Assets	11.50	0.39	8.19	1.97	0.77	0.13
Total Debt*	--	--	--	2.28	--	--
Net Current Assets	-10.51	-7.06	4.01	-1.83	-0.09	-0.01

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-8.13	-11.42	-2.53	-2.12	-0.75
Cash Flow from Investing Activities	--	0.00	0.00	0.00	0.00	0.00
Cash from Financing Activities	--	0.24	17.56	4.35	2.18	0.60
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	-0.55	-1.21	-0.77	-0.18	-0.05
Cash EPS ($)	--	-0.55	-1.21	-0.77	-0.18	-0.05
Adjusted Book Value ($)	--	--	0.19	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.39	-0.54	-0.17	-0.14	-0.05
Free Cash Flow per Share ($)	--	-0.39	-0.54	-0.17	-0.14	-0.05

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	762.62	-1,140.84	-6,259.39	6,100.70	-1,425.20
ROE (%)	--	762.62	-2,332.57	1,208.80	6,100.70	-1,425.20
ROA (%)	-86.03	-270.63	-501.83	-842.67	-594.91	-397.08
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	51.84	57.61	-172.11	-277.55	-292.14	-73.53
Net Profit Growth (%)	58.13	54.47	-120.40	-330.07	-292.14	--
EPS Growth (%)	--	0.54	-0.56	-3.30	-2.92	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.18	-1.35	-19.21	--	--
Price / Book Value	2.42	-0.29	8.58	-121.36	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.12	-0.17	-0.96	-21.93	--	--
Close Price ($)	0.05	0.10	1.64	14.84	--	--
High Price ($)	0.58	1.79	19.95	47.86	--	--
Low Price ($)	0.04	0.06	1.58	5.34	--	--
Market Cap ($ Cr)	0.02	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	--	--	-1.25	--	--
Short term debt to equity ratio	--	--	--	-1.25	--	--
Current Ratio	0.05	0.05	1.96	0.52	0.90	0.96
Quick Ratio	0.05	--	--	--	0.04	--
Interest Coverage	--	--	-35.67	-14.38	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.